Related Experiment Videos
Orbital myositis, vitiligo, and giant cell myocarditis
A W Stevens1, M E Grossman, M L Barr
1Dermatology Consultation Service, Columbia-Presbyterian Medical Center, New York, NY, USA.
Insights
Giant cell myocarditis is a rare, aggressive heart condition. Early monitoring is crucial for patients with inflammatory orbital myopathy due to its potentially fatal course.
Area of Science:
- Cardiology
- Ophthalmology
- Immunology
Background:
- Giant cell myocarditis (GCM) is a rare, idiopathic inflammatory heart disease.
- It presents with rapid heart failure, arrhythmias, or sudden death.
- GCM is histologically defined by multinucleated giant cells.
Observation:
- Two prior cases linked GCM with idiopathic orbital myositis.
- This report details a similar case in a patient with vitiligo.
- The patient underwent diagnostic endomyocardial biopsy and received a cardiac transplant.
Findings:
- The patient survived due to cardiac transplantation.
- The case reinforces the association between GCM and orbital myopathy.
- Vitiligo was also noted in this patient.
Implications:
- Giant cell myocarditis requires vigilant monitoring in patients with inflammatory orbital myopathy.
- Prompt recognition and management are critical due to the fulminant nature of GCM.
- This association highlights the systemic inflammatory nature of these conditions.
Abstract:
Giant cell myocarditis is a rare idiopathic inflammatory heart disease characterized histologically by multinucleated giant cells, and clinically by rapid progressive heart failure, arrhythmias, or sudden death, often within hours to days of initial symptoms. There are two previously reported cases of giant cell myocarditis with idiopathic orbital myositis. We report a similar case in a patient who also had vitiligo, a diagnostic endomyocardial biopsy, and survival because of a cardiac transplant. Giant cell myocarditis should be monitored for in the course of inflammatory orbital myopathy because of its life-threatening fulminant course.